Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 71.50
0.00 (0.00%)
Jun 5, 2026, 1:30 PM CST
Excelsior Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 815.8 | 805.86 | 771.26 | 746.61 | 667.45 | 607.15 |
Depreciation & Amortization | 306.46 | 309.34 | 297.88 | 263.64 | 220.6 | 200.82 |
Other Amortization | 4.35 | 4.35 | 2.95 | 2.04 | 1.84 | 2.14 |
Loss (Gain) From Sale of Assets | 0.36 | - | -0.76 | -20.42 | -0.17 | -0.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | 2.18 | - |
Loss (Gain) From Sale of Investments | 2.67 | 1.87 | -1.86 | 0.69 | 1.72 | 6.64 |
Loss (Gain) on Equity Investments | -410.39 | -401.42 | -323.19 | -342.3 | -290.24 | -233.43 |
Stock-Based Compensation | 21.06 | - | - | - | - | - |
Provision & Write-off of Bad Debts | 3.16 | -3.86 | 0.49 | -0.9 | 13.22 | 7.05 |
Other Operating Activities | 179.26 | 196.94 | 180.32 | 245.82 | 172.32 | 150.8 |
Change in Accounts Receivable | -191.86 | 4.63 | -67.75 | -241.44 | -62.83 | -138.48 |
Change in Inventory | -50.78 | -88.47 | -264.07 | -139.99 | -312.96 | -121.87 |
Change in Accounts Payable | -71.15 | 162.95 | 4.11 | -27.92 | 52.86 | 65.26 |
Change in Unearned Revenue | 41.21 | 28.62 | -15.57 | 74.23 | 105.72 | 67.25 |
Change in Other Net Operating Assets | -339.36 | -2,384 | 1,888 | -452.94 | 65.43 | 331.73 |
Operating Cash Flow | 310.79 | -1,364 | 2,471 | 107.1 | 637.13 | 945.05 |
Operating Cash Flow Growth | 2.22% | - | 2207.58% | -83.19% | -32.58% | 8.70% |
Capital Expenditures | -81.41 | -77.79 | -114.87 | -126.37 | -171.6 | -164.69 |
Sale of Property, Plant & Equipment | -0.36 | - | 1.03 | 36.46 | 2.6 | 0.09 |
Cash Acquisitions | - | - | - | -3.86 | - | - |
Divestitures | - | - | - | - | 2.76 | - |
Sale (Purchase) of Intangibles | -3.91 | -5.25 | -5.83 | -16.27 | -0.85 | -4.06 |
Sale (Purchase) of Real Estate | - | - | -249.16 | - | -96.65 | -21.09 |
Investment in Securities | 34.54 | 208.99 | -48.13 | 35.49 | -740.12 | 256.11 |
Other Investing Activities | 128.62 | 98.94 | 351.39 | 180.3 | 313.86 | 77.76 |
Investing Cash Flow | 77.48 | 224.89 | -65.57 | 105.75 | -690.01 | 144.13 |
Short-Term Debt Issued | - | 425.69 | - | 599.75 | 55.17 | 75.47 |
Long-Term Debt Issued | - | 350 | - | - | - | - |
Total Debt Issued | 425.69 | 775.69 | - | 599.75 | 55.17 | 75.47 |
Short-Term Debt Repaid | - | - | -217.36 | - | - | - |
Long-Term Debt Repaid | - | -137.28 | -101.27 | -97.7 | -82.58 | -79.69 |
Total Debt Repaid | -697.48 | -137.28 | -318.63 | -97.7 | -82.58 | -79.69 |
Net Debt Issued (Repaid) | -271.79 | 638.41 | -318.63 | 502.05 | -27.41 | -4.22 |
Issuance of Common Stock | 1,008 | - | - | - | - | - |
Common Dividends Paid | -620.91 | -620.91 | -591.34 | -540.95 | -494.02 | -494.02 |
Other Financing Activities | -172.47 | -166.48 | -45.99 | -65.61 | -112.46 | -95.67 |
Financing Cash Flow | -57.17 | -148.98 | -955.96 | -104.51 | -633.89 | -593.91 |
Foreign Exchange Rate Adjustments | -50.1 | -54.35 | 124.5 | -0.54 | 121.5 | -41.47 |
Net Cash Flow | 281.01 | -1,342 | 1,574 | 107.79 | -565.27 | 453.8 |
Free Cash Flow | 229.37 | -1,441 | 2,357 | -19.27 | 465.53 | 780.36 |
Free Cash Flow Growth | 28.86% | - | - | - | -40.34% | -6.96% |
Free Cash Flow Margin | 2.55% | -16.40% | 27.60% | -0.23% | 6.48% | 11.87% |
Free Cash Flow Per Share | 1.29 | -8.37 | 13.68 | -0.11 | 2.70 | 4.52 |
Cash Interest Paid | 31.33 | 31.33 | 29.53 | 17.9 | 10.07 | 8.57 |
Cash Income Tax Paid | 204.58 | 204.58 | 228.43 | 151.61 | 109.31 | 103.05 |
Levered Free Cash Flow | 329.16 | -1,522 | 2,521 | -84.71 | 384.73 | 685.1 |
Unlevered Free Cash Flow | 342.67 | -1,508 | 2,533 | -75.76 | 388.43 | 687.38 |
Change in Working Capital | -611.94 | -2,277 | 1,544 | -788.07 | -151.79 | 203.89 |